Burns
Volume 30 , Pages S1-S9 , July 2004

The role of Acticoat™ with nanocrystalline silver in the management of burns

References 

  1. Wright JB, Lam K, Hanson D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Inf Cont. 1999;27:344–350
  2. Klein DG, Fritsch DE, Amin SG. Wound infection following trauma and burn injuries. Crit Care Nursing Clin NA. 1995;7:627–642
  3. Bragg PD, Rainnie DJ. The effect of silver ions on the respiratory chain of E coli. Can J Microbiol. 1974;20:883–889
  4. Cervantes C, Silver S. Metal resistance in Pseudomonas: genes and mechanisms. In:  Nakazawa T,  Furukawa K,  Haas D,  Silver S editor. Molecular Biology of Pseudomonas. Washington: American Society for Microbiology; 1996;
  5. Modak SM, Fox CL. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol. 1973;22:2391–2404
  6. Rosenkranz HS, Rosenkranz S. Silver sulfadiazine: interaction with isolated deoxyribonucleic acid. Antimicrob Agents Chemother. 1972;2:373–383
  7. Grier N. Silver and its compounds. In:  Block SS editors. Disinfection, Sterilization and Preservation. 3rd ed. Philadelphia, PA: Lea & Febiger; 1983;
  8. Demling RH, DeSanti L. Effects of silver on wound management. Wounds. 2001;13:4–9
  9. Monafo WW, Moyer CA. The treatment of extensive thermal burns with 0.5% silver nitrate solution. Ann NY Acad Sci. 1968;150:937–945
  10. Fox CL. Silver sulfadiazine — a new topical therapy for Pseudomonas in burns. Arch Surg. 1968;96:184–188
  11. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of Acticoat™ antimicrobial barrier dressing. J Burn Care and Rehab. 1999;20:195–200
  12. Ricketts CR, Lowbury EJ, Lawrence JC, Hall M, Wilkins MD. Mechanism of prophylaxis by silver compounds against infection of burns. BMJ. 1970;1:444–446
  13. Spacciapoli P, Buxton D, Rothstein D, Friden P. Antimicrobial activity of silver nitrate against periodontal pathogens. J Periodontal Res. 2001;36:108–113
  14. Hall RE, Bender G, Marquis RE. Inhibitory and cidal antimicrobial actions of electrically generated silver ions. J Oral Maxillofac Surg. 1987;45:779–784
  15. Maple PA, Hamilton-Miller JM, Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin resistant Staphylococcus aureus. J Antimicrobial Chemotherapy. 1992;29:661–668
  16. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings. Wounds. 1998;10:179–188
  17. Burrell RE, Heggers JP, Davis GJ, Wright JB. Efficacy of silver-coated dressings as bacterial barriers in a rodent burn sepsis model. Wounds. 1999;11:64–71
  18. Tredget EE, Shankowsky HA, Groenveld A, Burrell R. A matched-pair randomized study evaluating the efficacy and safety of Acticoat silvercoated dressing for the treatment of burn wounds. J Burn Care Rehab. 1998;19:531–537
  19. Woodward RL. Review of the bactericidal effectiveness of silver. J Am Water Works Assoc. 1963;55:881–886
  20. Yager DR, Zhang L-Y, Liang H-X, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels compared to surgical wound fluids. J Invest Dermatol. 1996;107:743–748
  21. Trengove NJ, Stacey MC, Macaulley S, Bennett N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Regen. 1999;7:442–452
  22. Rogers AA, Burnett S, Moore JC, Shakespeare PG, Chen WYJ. Involvement of proteolytic enzymes (plasminogen activators and matrix metalloproteinases) in the pathophysiology of pressure ulcers. Wound Rep Regen. 1995;3:273–283
  23. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis and healing. Wound Rep Reg. 2002;10:141–151
  24. Paddock HN, Schultz GS, Perrin KJU, Moldawer LL, Wright B, Burrell RE, et al. Clinical assessment of silver-coated antimicrobial dressing on MMPs and cytokine levels in non-healing wounds. In: Ann Meeting Presentation. Wound Healing Society. Baltimore, MD. 2002;
  25. Demling RH, DeSanti L. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns. 2002;28:264–266
  26. Olson ME, Wright JB, Lam K, Burrell RE. Healing of porcine donor sites covered with silver-coated dressings. Eur J Surg. 2000;166:486–489
  27. Stephens R, Silverstein P, Meites H, Jett M, Brou J. An evaluation of Acticoat dressing with regard to cost and control of infection. In: 31st Annual Meeting of the American Burn Association. Orlando. 1999;
  28. Li XZ, Nikaido H, Williams KE. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins. J Bacteriol. 1997;179:6127–6132
  29. Gupta A, Maynes M, Silver S. Effects of halides on plasmid-mediated silver resistance in Escherichia coli. App Env Microbiol. 1998;64:5042–5045
  30. Liedberg H, Lundeberg T. Assessment of silver-coated urinary catheter toxicity by cell culture. Urol Res. 1989;17:359–360
  31. Baldi C, Minoia C, Di Nuici A, Capodaglio E, Manzo L. Effects of silver in isolated rat hepatocytes. Toxicol Lett. 1988;41:261–268
  32. Hussain S, Anner RM, Anner BM. Cysteine protects Na, K-ATPase and isolated human lymphocytes from silver toxicity. Biochem Biophys Res Common. 1992;189:1444–1449
  33. Bador K. Organ deposition of silver following silver nitrate therapy for burns. PRS. 1966;37:550
  34. Coombs CJ, Wan AT, Masterton JP, Conyers RA, Pedersen J, Chia YT. Do burn patients have a silver lining?. Burns. 1992;18:179–184
  35. McCauley RL, Linares HA, Pelligrini V, Herndon DN, Robson MC, Haggers JP. In vitro toxicity of topical antimicrobial agents to human fibroblasts. J Surg Res. 1989;46:267–274
  36. Kuroyanagi Y, Kim E, Shioya N. Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine. J Burn Care Rehab. 1991;12:106–115
  37. Geronemus RG, Mertz PM, Eaglstein NH. Wound healing. The effects of topical antimicrobial agents. Arch Dermatol. 1979;115:1311–1314

☆ This paper is based on presentations given during a symposium and related sessions at the 2003 European Burns Association meeting by: Professor Robert E Burrell, Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada Professor Robert Demling, Professor of Surgery, Harvard Medical School, Boston, MA, USA Dr Simone Pancani, Paediatric Burn Unit, Department of Paediatric Surgery, Anna Meyer Children's Hospital, Florence, Italy Dr Anthony Papp, Burn Unit, Kuopio University Hospital, Finland Dr Ole Strand, Paediatric Surgery, Astrid Lindgren Children's Hospital, Karolinska Hospital, Stockholm, Sweden Dr Veronique Voinchet, Paediatric Burns Unit, Marseille, France The symposium was chaired by Dr Thomas Sjoberg of the University Hospital, Tromso, Norway

PII: S0305-4179(04)90000-9

Burns
Volume 30 , Pages S1-S9 , July 2004

Article Tools